vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and Tronox Holdings plc (TROX). Click either name above to swap in a different company.

Tronox Holdings plc is the larger business by last-quarter revenue ($730.0M vs $719.4M, roughly 1.0× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs -24.1%, a 97.3% gap on every dollar of revenue. On growth, Tronox Holdings plc posted the faster year-over-year revenue change (8.0% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $53.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -2.9%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Tronox Limited is an American worldwide chemical company involved in the titanium products industry with approximately 6,500 employees. Following its acquisition of the mineral sands business formerly belonging to South Africa's Exxaro Resources, Tronox is the largest fully integrated seller and marketer of titanium dioxide (TiO2) pigment, which provides brightness to applications such as coatings, plastics and paper. Tronox mines titanium-bearing mineral sands and operates upgrading faciliti...

DOC vs TROX — Head-to-Head

Bigger by revenue
TROX
TROX
1.0× larger
TROX
$730.0M
$719.4M
DOC
Growing faster (revenue YoY)
TROX
TROX
+4.9% gap
TROX
8.0%
3.1%
DOC
Higher net margin
DOC
DOC
97.3% more per $
DOC
73.2%
-24.1%
TROX
More free cash flow
DOC
DOC
$304.0M more FCF
DOC
$357.0M
$53.0M
TROX
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-2.9%
TROX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOC
DOC
TROX
TROX
Revenue
$719.4M
$730.0M
Net Profit
$114.0M
$-176.0M
Gross Margin
5.3%
Operating Margin
17.4%
-15.6%
Net Margin
73.2%
-24.1%
Revenue YoY
3.1%
8.0%
Net Profit YoY
2406.4%
-486.7%
EPS (diluted)
$0.16
$-1.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
TROX
TROX
Q4 25
$719.4M
$730.0M
Q3 25
$705.9M
$699.0M
Q2 25
$694.3M
$731.0M
Q1 25
$702.9M
$738.0M
Q4 24
$698.0M
$676.0M
Q3 24
$700.4M
$804.0M
Q2 24
$695.5M
$820.0M
Q1 24
$606.6M
$774.0M
Net Profit
DOC
DOC
TROX
TROX
Q4 25
$114.0M
$-176.0M
Q3 25
$-117.1M
$-99.0M
Q2 25
$31.7M
$-84.0M
Q1 25
$42.8M
$-111.0M
Q4 24
$4.5M
$-30.0M
Q3 24
$85.9M
$-25.0M
Q2 24
$146.0M
$16.0M
Q1 24
$6.7M
$-9.0M
Gross Margin
DOC
DOC
TROX
TROX
Q4 25
5.3%
Q3 25
58.6%
7.4%
Q2 25
60.2%
10.8%
Q1 25
61.1%
13.4%
Q4 24
60.3%
17.3%
Q3 24
60.0%
15.9%
Q2 24
60.6%
18.3%
Q1 24
59.8%
15.5%
Operating Margin
DOC
DOC
TROX
TROX
Q4 25
17.4%
-15.6%
Q3 25
9.2%
-6.2%
Q2 25
5.7%
-4.8%
Q1 25
7.7%
-8.3%
Q4 24
-2.2%
7.1%
Q3 24
14.1%
6.7%
Q2 24
22.3%
9.3%
Q1 24
3.7%
5.3%
Net Margin
DOC
DOC
TROX
TROX
Q4 25
73.2%
-24.1%
Q3 25
-16.6%
-14.2%
Q2 25
4.6%
-11.5%
Q1 25
6.1%
-15.0%
Q4 24
0.7%
-4.4%
Q3 24
12.3%
-3.1%
Q2 24
21.0%
2.0%
Q1 24
1.1%
-1.2%
EPS (diluted)
DOC
DOC
TROX
TROX
Q4 25
$0.16
$-1.11
Q3 25
$-0.17
$-0.63
Q2 25
$0.05
$-0.53
Q1 25
$0.06
$-0.70
Q4 24
$0.02
$-0.19
Q3 24
$0.12
$-0.16
Q2 24
$0.21
$0.10
Q1 24
$0.01
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
TROX
TROX
Cash + ST InvestmentsLiquidity on hand
$467.5M
$199.0M
Total DebtLower is stronger
$9.8B
$3.1B
Stockholders' EquityBook value
$7.5B
$1.4B
Total Assets
$20.3B
$6.2B
Debt / EquityLower = less leverage
1.31×
2.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
TROX
TROX
Q4 25
$467.5M
$199.0M
Q3 25
$91.0M
$185.0M
Q2 25
$89.4M
$132.0M
Q1 25
$70.6M
$138.0M
Q4 24
$119.8M
$151.0M
Q3 24
$180.4M
$167.0M
Q2 24
$106.9M
$201.0M
Q1 24
$101.8M
$152.0M
Total Debt
DOC
DOC
TROX
TROX
Q4 25
$9.8B
$3.1B
Q3 25
$9.1B
$3.1B
Q2 25
$9.0B
$2.7B
Q1 25
$8.9B
$2.8B
Q4 24
$8.7B
$2.8B
Q3 24
$8.6B
$2.8B
Q2 24
$8.6B
$2.8B
Q1 24
$8.8B
$2.8B
Stockholders' Equity
DOC
DOC
TROX
TROX
Q4 25
$7.5B
$1.4B
Q3 25
$7.6B
$1.6B
Q2 25
$7.9B
$1.6B
Q1 25
$8.2B
$1.7B
Q4 24
$8.4B
$1.8B
Q3 24
$8.6B
$1.9B
Q2 24
$8.8B
$1.9B
Q1 24
$8.9B
$1.9B
Total Assets
DOC
DOC
TROX
TROX
Q4 25
$20.3B
$6.2B
Q3 25
$19.6B
$6.3B
Q2 25
$19.8B
$6.2B
Q1 25
$19.8B
$6.1B
Q4 24
$19.9B
$6.0B
Q3 24
$20.0B
$6.2B
Q2 24
$20.2B
$6.1B
Q1 24
$20.5B
$6.0B
Debt / Equity
DOC
DOC
TROX
TROX
Q4 25
1.31×
2.21×
Q3 25
1.20×
2.01×
Q2 25
1.14×
1.67×
Q1 25
1.08×
1.64×
Q4 24
1.04×
1.57×
Q3 24
1.00×
1.45×
Q2 24
0.98×
1.47×
Q1 24
0.99×
1.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
TROX
TROX
Operating Cash FlowLast quarter
$1.3B
$121.0M
Free Cash FlowOCF − Capex
$357.0M
$53.0M
FCF MarginFCF / Revenue
49.6%
7.3%
Capex IntensityCapex / Revenue
124.4%
9.3%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters
$-281.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
TROX
TROX
Q4 25
$1.3B
$121.0M
Q3 25
$315.0M
$-57.0M
Q2 25
$363.5M
$28.0M
Q1 25
$279.4M
$-32.0M
Q4 24
$1.1B
$82.0M
Q3 24
$318.2M
$87.0M
Q2 24
$316.2M
$160.0M
Q1 24
$152.6M
$-29.0M
Free Cash Flow
DOC
DOC
TROX
TROX
Q4 25
$357.0M
$53.0M
Q3 25
$-137.0M
Q2 25
$-55.0M
Q1 25
$-142.0M
Q4 24
$333.7M
$-35.0M
Q3 24
$-14.0M
Q2 24
$84.0M
Q1 24
$-105.0M
FCF Margin
DOC
DOC
TROX
TROX
Q4 25
49.6%
7.3%
Q3 25
-19.6%
Q2 25
-7.5%
Q1 25
-19.2%
Q4 24
47.8%
-5.2%
Q3 24
-1.7%
Q2 24
10.2%
Q1 24
-13.6%
Capex Intensity
DOC
DOC
TROX
TROX
Q4 25
124.4%
9.3%
Q3 25
11.4%
Q2 25
11.4%
Q1 25
14.9%
Q4 24
105.6%
17.3%
Q3 24
12.6%
Q2 24
9.3%
Q1 24
9.8%
Cash Conversion
DOC
DOC
TROX
TROX
Q4 25
10.99×
Q3 25
Q2 25
11.48×
Q1 25
6.52×
Q4 24
235.43×
Q3 24
3.71×
Q2 24
2.17×
10.00×
Q1 24
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOC
DOC

Segment breakdown not available.

TROX
TROX

Ti O2$577.0M79%
Zircon$78.0M11%
Idle Facility And Lower Of Cost Or Net Realizable Value Charges$42.0M6%
Other$20.0M3%
MGT$13.0M2%

Related Comparisons